Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of The Minimally Invasive VenTouch™ System in The Treatment of Functional Mitral Valve Regurgitation (FMR): OUS Feasibility Study

NCT03616678 is registered in ClinicalTrials.gov with Mardil Medical as lead sponsor.

NCT NCT03616678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03616678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of The Minimally Invasive VenTouch™ System in The Treatment of Functional Mitral Valve Regurgitation (FMR): OUS Feasibility Study
Lead sponsor
Mardil Medical
Phase
Not applicable
Overall status
Unknown status
Start date
March 25, 2019
Completion date
December 31, 2023
Enrollment
15 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

functional mitral regurgitation